Related Experiment Video
Updated: Jun 21, 2026

Histological Examination of Mitochondrial Morphology in a Parkinson's Disease Model
Published on: June 23, 2023
Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease
Rodrigo A Quintanilla1, Gail V W Johnson
1Department of Anesthesiology, University of Rochester, Rochester, NY 14642-0002, USA.
Insights
Huntington's disease (HD) involves CAG repeat expansion in huntingtin protein, impairing mitochondrial function. This leads to energy deficits, oxidative stress, and neuronal death, highlighting mitochondria's role in HD pathogenesis.
Area of Science:
- Neurodegenerative Disorders
- Mitochondrial Biology
- Molecular Genetics
Background:
- Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder.
- It is caused by a CAG repeat expansion in the huntingtin gene.
- The precise pathogenic mechanisms remain under investigation, but mitochondrial dysfunction is implicated.
Purpose of the Study:
- To review evidence linking mutant huntingtin to mitochondrial dysfunction in HD.
- To explore how impaired mitochondrial function contributes to neuronal death in HD.
- To examine the role of calcium homeostasis alterations in HD pathogenesis.
Main Methods:
- Review of existing literature on HD, huntingtin protein, and mitochondrial function.
- Analysis of studies investigating mitochondrial calcium uptake and respiration in HD models.
- Examination of research on oxidative stress and energy metabolism in HD.
Main Results:
- Mutant huntingtin directly or indirectly impairs mitochondrial function.
- Mitochondria in HD models exhibit altered calcium uptake and respiration.
- Compromised energy metabolism and increased oxidative damage are observed in HD.
Conclusions:
- Mitochondrial dysfunction is a key contributor to neuronal dysfunction and death in HD.
- Impaired mitochondrial calcium handling affects cellular homeostasis in HD.
- Targeting mitochondrial pathways may offer therapeutic strategies for HD.
Abstract:
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder that is caused by a pathological expansion of CAG repeats within the gene encoding for a 350 kD protein called huntingtin. This polyglutamine expansion within huntingtin is the causative factor in the pathogenesis of HD, however the underlying mechanisms have not been fully elucidated. Nonetheless, it is becoming increasingly clear that alterations in mitochondrial function play key roles in the pathogenic processes in HD. The net result of these events is compromised energy metabolism and increased oxidative damage, which eventually contribute to neuronal dysfunction and death. Mitochondria from striatal cells of a genetically accurate model of HD take up less calcium and at a slower rate than mitochondria from striatal cells derived from normal mice. Further, respiration in mitochondria from these mutant huntingtin-expressing cells is inhibited at significantly lower calcium concentrations compared to mitochondria from wild-type cells. Considering these and other findings this review explores the evidence suggesting that mutant huntingtin, directly or indirectly impairs mitochondrial function, which compromises cytosolic and mitochondrial calcium homeostasis, and contributes to neuronal dysfunction and death in HD.
Related Concept Videos
Huntington Disease l: Introduction
Mitochondria
Parkinson Disease ll: Pathophysiology
ATP Synthase: Mechanism
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
Translocation of Proteins into the Mitochondria
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...

